Ballicules.com

Isoniazid

INH

What it isInhA inhibitor that blocks mycobacterial mycolic-acid synthesis; active and latent tuberculosis.

Why this oneIt is strongly bactericidal against replicating bacilli and remains the backbone of latent-TB therapy.

What limits it⚑ Hepatitis risk rises with age and alcohol; give pyridoxine when neuropathy risk is present and review CYP interactions.

FDA-approved for

FDA label

BOXED WARNING Severe and sometimes fatal hepatitis; risk is age-related and increased by daily alcohol use — monitor symptoms monthly and hepatic enzymes (AST/ALT) in patients ≥35.
FDA dosingPopulationStartTargetMax
Active tuberculosis (with other agents)Adult5 mg/kg up to 300 mg QD15 mg/kg up to 900 mg 2-3x/week (intermittent)
Active tuberculosis (with other agents)Children10-15 mg/kg up to 300 mg QD20-40 mg/kg up to 900 mg 2-3x/week (intermittent)
TB preventive therapyAdults >30 kg300 mg QD20-30 mg/kg up to 900 mg twice weekly
TB preventive therapyInfants/children10 mg/kg up to 300 mg QD20-30 mg/kg up to 900 mg twice weekly

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Category C; used for active TB when benefit justifies risk; crosses placenta — observe neonate.

Lactation Low levels in breast milk; not considered to threaten the neonate (per pregnancy section).

⚠ BOXED WARNING

Cost, est. cash$20–$1,500/dose or month

Generic entry1982

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryC

Defining liabilityHepatotoxicity and neurotoxicity; pyridoxine is needed in at-risk patients.

Mechanism of action: Isoniazid ballicule

Isoniazid ballicule: receptor binding, kinetics and half-life diagram

Open Isoniazid in the interactive console ↗